CP-101,606

CP-101,606 · Pfizer

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CP-101,606, covering 2006-06-22 to 2006-09-22. Get the full timeline:

Most recent: Clinical Trial Update: The Antidepressant Effects Of The NMDA Antagonist, CP-101,606, In Patients With MDD [Phase 2]